{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:52:20Z","timestamp":1793641940205,"version":"4.5.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Proton pump inhibitors (PPIs) are widely prescribed medications. Various adverse clinical effects of PPIs have been reported in the literature, particularly over the past decade. The purpose of this article is to review published data primarily describing adverse effects associated with PPI use and to help clinicians determine which patients may still benefit from therapy despite safety concerns.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Associations between PPIs and the following have been described: bone fracture, acute and chronic kidney disease, gastrointestinal infections, deficiencies in vitamin B12 and magnesium, and coronavirus disease 2019 and respiratory infections. For inclusion in this review, studies must have evaluated potential adverse events associated with PPIs as a primary or secondary objective. Increased risks of bone fracture, acute and chronic kidney disease, gastrointestinal infections, and magnesium deficiency were consistently reported, albeit mostly in studies involving low-quality data (case-control and\/or observational studies) and subject to bias. In the only pertinent randomized controlled trial to date, chronic pantoprazole use was associated with a greater risk of enteric infections relative to placebo use; there was no significant between-group difference in any other adverse event evaluated. PPIs continue to be recommended by the American College of Gastroenterology as a first-line treatment for management of gastroesophageal reflux disease and in the acute period following upper gastrointestinal and ulcer bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Higher-quality data is needed to better understand PPI-associated risks of the adverse effects listed above. Until then, clinicians may consider greater vigilance with PPI use; however, the data does not demonstrate a need for wide adoption of de-escalation strategies solely out of safety concerns.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ajhp\/zxad009","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T16:39:30Z","timestamp":1673455170000},"page":"487-494","source":"Crossref","is-referenced-by-count":38,"title":["Proton pump inhibitors: Understanding the associated risks and benefits of long-term use"],"prefix":"10.1093","volume":"80","author":[{"given":"Kristina M","family":"Thurber","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley O","family":"Otto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mayo Clinic , Rochester, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna L","family":"Stricker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Nebraska Medicine, Omaha, NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.japh.2020.09.015","article-title":"National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017","volume":"61","author":"Mishuk","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11894-008-0098-4","article-title":"Pharmacology of proton pump inhibitors","volume":"10","author":"Moo Shin","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"key":"2023040806190261600_","author":"Food and Drug Administration","year":"2010"},{"key":"2023040806190261600_","author":"Food and Drug Administration","year":"2011"},{"key":"2023040806190261600_","author":"Food and Drug Administration","year":"2012"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11894-012-0290-4","article-title":"Chronic proton pump inihibitor therapy and calcium metabolism","volume":"14","author":"Yang","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-020-01794-3","article-title":"Comparing proton pump inhibitors with histamine-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease","volume":"20","author":"Park","year":"2020","journal-title":"BMC Geriatr"},{"key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"e0235163","DOI":"10.1371\/journal.pone.0235163","article-title":"Association between proton pump inhibitor use and risk of fracture: a population-based case-control study","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"115502","DOI":"10.1016\/j.bone.2020.115502","article-title":"Association between proton pump inhibitors use and risk of hip fracture: a general population-based cohort study","volume":"139","author":"Wei","year":"2020","journal-title":"Bone"},{"issue":"4","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/j.gastro.2018.11.023","article-title":"Dexlansoprazole and esomeprazole do not affect bone homeostasis in healthy postmenopausal women","volume":"156","author":"Hansen","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.metabol.2012.09.011","article-title":"Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study","volume":"62","author":"Sharara","year":"2013","journal-title":"Metabolism"},{"issue":"10","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1681\/ASN.2016020192","article-title":"Proton pump inhibitors and CKD","volume":"27","author":"Moledina","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2369-14-150","article-title":"Proton pump inhibitors and acute kidney injury: A nested case-control study","volume":"14","author":"Klepser","year":"2013","journal-title":"BMC Nephrol"},{"issue":"4","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","article-title":"A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use","volume":"86","author":"Blank","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jgh.15151","article-title":"Acute kidney injury following the use of different proton pump inhibitor regimens: a real-world analysis of post-marketing surveillance data","volume":"36","author":"Chen","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","author":"Xie","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.kint.2016.12.021","article-title":"Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury","volume":"91","author":"Xie","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12882-016-0325-4","article-title":"Proton pump inhibitors are associated with increased risk of development of chronic kidney disease","volume":"17","author":"Arora","year":"2016","journal-title":"BMC Nephrol"},{"issue":"2","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ndt\/gfw470","article-title":"The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis","volume":"33","author":"Nochaiwong","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1093\/cid\/ciaa1857","article-title":"Proton-pump inhibitor use and the risk of community-associated Clostridium difficile infection","volume":"72","author":"Inghammar","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.cgh.2007.09.010","article-title":"Use of acid-suppressing drugs and the risk of bacterial gastroenteritis","volume":"5","author":"Garc\u00eda Rodr\u00edguez","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MOG.0000000000000414","article-title":"Proton pump inhibitors and risk of Clostridium difficile infection","volume":"34","author":"Villafuerte-G\u00e1lvez","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"issue":"12","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"e0168618","DOI":"10.1371\/journal.pone.0168618","article-title":"Use of proton pump inhibitors and the risk of hospitalization for infectious gastroenteritis","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10654-016-0136-8","article-title":"Proton pump inhibitors and gastroenteritis","volume":"31","author":"Hassing","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11894-010-0141-0","article-title":"Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium","volume":"12","author":"Ito","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10408363.2021.1885339","article-title":"Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency \u2013 clinical and laboratory pitfalls","volume":"58","author":"Sobczy\u0144ska-Malefora","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"22","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3889\/oamjms.2018.142","article-title":"Proton pump inhibitors intake and iron and vitamin B12 status: a prospective comparative study with a follow up of 12 months","volume":"6","author":"Qorraj-Bytyqi","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"issue":"17","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N Engl J Med"},{"key":"2023040806190261600_","author":"Food and Drug Administration","year":"2011"},{"issue":"3","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2042098613482484","article-title":"Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications","volume":"4","author":"Heidelbaugh","year":"2013","journal-title":"Ther Adv Drug Saf"},{"issue":"44","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"e17788","DOI":"10.1097\/MD.0000000000017788","article-title":"Proton pump inhibitors and hypomagnesemia","volume":"98","author":"Srinutta","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1155\/2008\/821385","article-title":"Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials","volume":"22","author":"Sultan","year":"2008","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.gastro.2020.09.028","article-title":"Effect of acid suppressants on the risk of COVID-19: a propensity score-matched study using UK Biobank","volume":"160","author":"Fan","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.arcmed.2021.03.004","article-title":"Proton pump inhibitors: current use and the risk of coronavirus infectious disease 2019 development and its related mortality. Meta-analysis","volume":"52","author":"Toubasi","year":"2021","journal-title":"Arch Med Res"},{"issue":"5","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/apt.13304","article-title":"Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies","volume":"42","author":"Estborn","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2036.2010.04284.x","article-title":"proton pump inhibitor use and the risk of community-acquired pneumonia","volume":"31","author":"Johnstone","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2021.12.247","article-title":"AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review","volume":"162","author":"Targownik","year":"2022","journal-title":"Gastroenterology"},{"issue":"5","key":"2023040806190261600_","doi-asserted-by":"crossref","first-page":"899","DOI":"10.14309\/ajg.0000000000001245","article-title":"ACG clinical guideline: upper gastrointestinal and ulcer bleeding","volume":"116","author":"Laine","year":"2021","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxad009\/49168931\/zxad009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/80\/8\/487\/49800425\/zxad009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/80\/8\/487\/49800425\/zxad009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T13:31:19Z","timestamp":1701696679000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/80\/8\/487\/6984586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,1,11]]},"published-print":{"date-parts":[[2023,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxad009","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,15]]},"published":{"date-parts":[[2023,1,11]]}}}